Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens.

ABSTRACT: Adenoviruses represent the most widely used viral-vectored platform for vaccine design, showing a great potential in the fight against intracellular infectious diseases to which either there is a lack of effective vaccines or the traditional vaccination strategy is suboptimal. The extensive understanding of the molecular biology of adenoviruses has made the new technologies and reagents available to efficient generation of adenoviral-vectored vaccines for both preclinical and clinical evaluation. The novel adenoviral vectors including nonhuman adenoviral vectors have emerged to be the further improved vectors for vaccine design. In this review, we discuss the latest adenoviral technologies and their utilization in vaccine development. We particularly focus on the application of adenoviral-

SUBMITTER: Afkhami S 

PROVIDER: S-EPMC4847555 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature